Clinical Trials · NCT06277336
Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University Hospital, Basel, Switzerland
- Enrollment
- 15
- Start date
- Mar 2024
- Locations
- 1 site, Switzerland
- Primary endpoint
- Total urinary excretion (ml)